Login / Signup

Clostridioides difficile infection recurrence in the VINCat hospitals: a prospective observational cohort study.

Miquel PujolEnric LimónNieves SopenaJoaquín López-ContrerasLaia CastelláJordi CuquetMaria López-SánchezRafel PérezCarlota GudiolAna ColomaMariló MarimónJoan EspinachMarta AndresPurificación MartosSergi HernándezAlexander AlmendralPatrick SalibaGonçalo Carvalho RodriguesEsther CalboVINCat Program Group
Published in: Future microbiology (2022)
Background: The 2016 cumulative incidence of Clostridioides difficile infection (CDI) in Spain was reported by the European Center for Disease Control to be above the mean of other European countries. The aim of this multicenter prospective observational cohort study was to examine the risk factors that determine 90-day CDI recurrence in Catalonia, Spain. Methods: The study included 558 consecutive adults admitted to hospital who had a symptomatic, first positive CDI diagnosis. Sociodemographic, clinical and epidemiological variables were recorded. The primary outcome was 90-day CDI recurrence. Results: In this Catalan population, having received more than one course of antibiotics in the 30 days prior to CDI diagnosis (odds ratio: 2.459; 95% CI: 1.195-5.060; p = 0.015) and active chemotherapy (odds ratio: 4.859; 95% CI: 1.495-15.792; p = 0.009) are significant predictors of 90-day CDI recurrence. Conclusion: The identification of independent risk factors of 90-day CDI recurrence will enable the optimization of preventive measures in at-risk populations.
Keyphrases
  • risk factors
  • free survival
  • clostridium difficile
  • healthcare
  • squamous cell carcinoma
  • emergency department
  • electronic health record
  • genetic diversity